Drug
Oral Sodium Phenylbutyrate clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 1997
How studies write it
Studies that test it under each name
Name
- oral sodium phenylbutyrate
- 3
Studies by the year they started
3 studies that test it; most in 1997 (1)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2000 | 1 |
| 2006 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
National Heart, Lung, and Blood Institute (NHLBI) (1) · National Cancer Institute (NCI) (1) · University of California, San Diego (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Oral Sodium Phenylbutyrate is read from its arms, and is right about nine times in ten.
Testing it · 3
- Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive CancerWithdrawnPhase 2University of California, San DiegoNCT00387530Written as oral sodium phenylbutyrate
- Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid LeukemiaCompletedPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT00006240Written as oral sodium phenylbutyrate
- Phenylbutyrate in Treating Patients With Refractory Solid Tumors or LymphomaCompletedPhase 1National Cancer Institute (NCI)NCT00002909Written as oral sodium phenylbutyrate